Vaccines: latest news

Vaccines resources

  • Vaccines

    HIV vaccine researchers are still looking for a vaccine that would offer a significant degree of protection against HIV infection....

    From: Preventing HIV

    Information level Level 4
  • Vaccines

    The promise of an effective HIV vaccine has always been just over the horizon, but more than 20 years after the identification of HIV, vaccines...

    From: HIV transmission & testing

    Information level Level 4

Vaccines features

Vaccines news from aidsmap

More news

Vaccines news selected from other sources

  • HPV vaccine works even better than expected, study finds

    The vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, appears even more effective than believed, a new study finds. “After eight years of vaccination, the reduction in the incidence of cervical neoplasia [abnormal growth of cells], including pre-cancers, have been reduced approximately 50 percent. This is greater than what was expected – that’s pretty exciting,” said lead researcher Cosette Wheeler.

    04 October 2016 | CBS
  • Broadly neutralizing HIV antibodies pave the way for vaccine

    A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zurich now reveal which factors are responsible for the human body forming such broadly neutralizing HIV antibodies, thereby opening new avenues for the development of an HIV vaccine.

    27 September 2016 | Medical Xpress
  • Understanding the Rationale for the HVTN 702 Trial

    What have scientists learned that helped inform the design of this pivotal AIDS vaccine study in South Africa?

    22 August 2016 | Vax Report
  • New vigour in HIV vaccine research evident at AIDS 2016

    Current and forthcoming studies of vaccines to prevent HIV infection have created a new optimism that the long and challenging road to the development of such a vaccine has begun to take some promising turns. Updates on the search for preventive vaccines, presented at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa, included information on advances in the development of novel vaccines, and in the field of antibody mediated prevention (AMP).

    19 July 2016 | AIDS 2016
  • Treatment Action Group: Pipeline Report 2016

    Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

    15 July 2016 | Treatment Action Group
  • HIV study confirms clinically viable vaccine paving the way for future treatments

    In the study, researchers worked with a species of Old World monkeys, rhesus macaques to reproduce the trial results of RV144, the only HIV vaccine that has been tested and shown to reduce the rate of HIV acquisition in a phase III clinical trial.

    08 July 2016 | Eurekalert Inf Dis
  • Five Exciting HIV Prevention Studies We’re Paying Attention To

    What’s on the horizon of HIV prevention? Here are five clinical trials to pay attention to, if you’re interested in what the next big breakthrough in the HIV prevention field may be.

    30 June 2016 | BETA blog
  • Improving the Effect of HIV Drugs by Use of the Tat Vaccine

    A phase II clinical trial conducted in South Africa has confirmed that the therapeutic Tat vaccine against HIV/AIDS can effectively improve the response to antiretroviral drugs in people living with HIV. The results are published today in the peer-review open access Journal Retrovirology.

    13 June 2016 | Istituto Superiore di Sanità press release
  • Men to get HPV vaccine in new drive to combat cancer, announces health minister Jane Ellison

    The first men in England have started receiving the vaccination as part of a pilot to stamp out cancers and genital disease. The scheme went live in two clinics this week and will eventually see 40,000 men vaccinated to protect them against penile, anal and other cancers. The project is specifically targeted at men who have sex with men, but ministers are exploring the possibility of rolling out the HPV vaccine to all boys.

    08 June 2016 | Evening Standard
  • New HIV-Mimicking Particles That Trigger Immune Response Could Advance AIDS Vaccine Design

    Researchers with the International Aids Vaccine Initiative (IAVI) and The Scripps Research Institute (TSRI) have built tiny particles that resemble HIV on their outside and used them to provoke an immune response in animals. Their work, which was published today in the journal Cell Reports, could advance the design of an effective AIDS vaccine.

    23 May 2016 | IAVI
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap